NEWAMSTERDAM PHARMA COMPANY (NAMSW) — institutional ownership

11 funds reported holding NEWAMSTERDAM PHARMA COMPANY in their latest 13F filings, worth $29.7M in total (CUSIP N62509117).

Largest holders

1. Frazier Life Sciences Management, L.P. — $10.7M
2. RA CAPITAL MANAGEMENT, L.P. — $7.12M
3. Affinity Asset Advisors, LLC — $5.34M
4. Bain Capital Life Sciences Investors, LLC — $2.14M
5. DEERFIELD MANAGEMENT COMPANY, L.P. — $1.98M
6. MILLENNIUM MANAGEMENT LLC — $1.60M
7. ARISTEIA CAPITAL, L.L.C. — $343K
8. WOLVERINE ASSET MANAGEMENT LLC — $319K
9. Vestcor Inc — $143K
10. CIBC Private Wealth Group LLC — $25.3K

Famous investors holding it

• Izzy Englander portfolio (Millennium Management)

Insider buying and selling at NEWAMSTERDAM PHARMA COMPANY

Who owns the most NAMSW stock?

The largest institutional holders in the latest 13F filings are Frazier Life Sciences Management, L.P. ($10.7M), RA CAPITAL MANAGEMENT, L.P. ($7.12M), Affinity Asset Advisors, LLC ($5.34M).

How many funds own NAMSW?

11 funds reported holding it, worth $29.7M in total.